Mesna shortage — BE supply status & alternatives

Mesna

—

🇦🇺 AUST R 46627 · Baxter Healthcare Pty Ltd

In supply · Australia

Uromitexan

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇩🇪 DE🇮🇹 IT🇧🇪 BE🇳🇴 NO

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$51.74details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes

Active ingredient (INN)	Mesna
Brand names	Uromitexan
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
Controlled substance	No
Marketing-authorisation holders	BAXTER HEALTHCARE LIMITED, HIKMA PHARMACEUTICALS USA INC., Baxter Healthcare Pty Ltd, INGENUS PHARMACEUTICALS, LLC +1 more
Registrations on file	12
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$51.74

AEMP

Dispensed (DPMQ)

—

incl. fees

Pack

mesna 400 mg/4 mL injection, 15 x 4 mL ampoules

Source: PBSEffective July 2026 · AUD

Other markets

🇪🇸 ES

€16.05

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

5 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Zhejiang Hisun Pharmaceutical CO LTDAarti Pharmalabs LTDBaxter Healthcare CorpSolara Active Pharma Sciences LTDSuzhou Ryway Biotech CO LTD

Manufacturing countries: China, India, United States · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇨🇦

Canada

HC · 2h ago

Critical

🇧🇪

FAMHP · 4h ago

High

🇩🇪

Germany

BfArM · 1d ago

High

🇮🇹

Italy

AIFA · 8h ago

Medium

🇳🇴

Norway

NOMA · 3d ago

Medium

🇪🇸

Spain

AEMPS · 1mo ago

Resolved

Verified timeline regulator events

🇩🇪 1 July 2026

high reported

🇨🇦 16 June 2026

high reported

🇨🇦 15 June 2026

critical reported

🇧🇪 15 June 2026

high reported

🇳🇴 15 June 2026

medium reported

🇨🇦 4 Apr 2026

high reported

Sources official regulators

🇨🇦

verified 2h ago

verify ↗

🇧🇪

FAMHP

verified 4h ago

verify ↗

🇮🇹

AIFA

verified 8h ago

verify ↗

🇩🇪

BfArM

verified 1d ago

verify ↗

🇳🇴

NOMA

verified 3d ago

verify ↗

🇪🇸

AEMPS

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders12 registrations · 5 MA holders

Product	Strength	Form	Market	MA holder	Status
MESNA INJECTION	—	injection	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
MESNA TABLETS 400 MG	400 MG	tablet	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
MESNA TABLETS 600 MG	600 MG	tablet	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
mesna	100mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
UROMITEXAN mesna	400mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
UROMITEXAN mesna	1g	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
UROMITEXAN mesna	600mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
Claris	200 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
Claris	400 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
Claris	1000 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
MESNA	400mg/1	tablet	🇺🇸 US	INGENUS PHARMACEUTICALS, LLC	Active
Mesna For	—	solution	🇨🇦 CA	FRESENIUS KABI CANADA LTD	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.